Biacore. Concentration Analysis Handbook

Similar documents
SURFACE PLASMON RESONANCE-BASED SYSTEMS

Validation of a concentration assay using Biacore C

GE Healthcare Life Sciences. Biacore Assay Handbook

Label-free interaction analysis in realtime using surface plasmon resonance

GE Biacore T Check that the waste bottle is empty.

The World Leader in SPR Technology. Jimmy Page, PhD, Biacore, Inc.

Application of Biacore Technology

Label-Enhanced SPR Improves the Detectability of Label-Free Surface Plasmon Resonance Analysis 100x

protein interaction analysis tech note 5367

Improving biosensor analysis

Solvent Correction versus In-line Reference Measurement

Surface plasmon resonance

Reducing Non-Specific Binding in Surface Plasmon Resonance Experiments

Real-Time Biomolecule Interaction Analysis Biacore

protein interaction analysis

Direct genotyping of C3435T single nucleotide polymorphism in unamplified human MDR1 gene using a surface plasmon resonance imaging DNA sensor

Towards an optimized in-vitro SPR assay for antibody Fcg receptor binding kinetics

Protein Interaction Analysis

The use of surface plasmon resonance to guide the choice of nucleic acid oligomers for co-crystallisation with proteins

Biacore System description. GE Healthcare. Biacore label-free interaction analysis. Optional software packages

Sensitive protein:ligand biochemical assays using Corning Epic label-free technology on the EnSpire Multimode Plate Reader

Ligand Binding Assay strategies to support early drug development. Sarah Childs, Tina Panchal, Rose Edwards GlaxoSmithkline

How to run Alpha assay: How to setup an Alpha assay Make your own assay!

Characterization of Aptamer Binding using SensíQ SPR Platforms

Biacore The high performance research system. Work with high sensitivity

M-Beads Magnetic Silica Beads Tools

Binding Analysis of a Novel Peptide to Malaria Knob Protein

Supporting Information

PI3 Kinase Assay Kit. Catalog Number KA assays Version: 05. Intended for research use only.

Design and Validation of a Non Cell-based Receptor Binding Assay for the Detection of Neutralizing Antibodies to a Biological Therapeutic

Characterization of a human recombinant antibody fragment to be used in a diagnostic test

Cyfra 21-1 IRMA. Product information Information about other products is available at: Userś Manual DE52100

Fragment-based screening of enzyme drug targets: Microfluidic mobility shift assay improves confidence in candidate selection

TAG-LITE RECEPTOR LIGAND BINDING ASSAY

Assays and Strategies for Immunogenicity Assessment. Steven J Swanson, Ph.D. Executive Director, Medical Sciences Clinical Immunology, Amgen

AppNote 5/2006 ABSTRACT

Comparison of LANCE Ultra TR-FRET to PerkinElmer s Classical LANCE TR-FRET Platform for Kinase Applications

Masayoshi Honda, Jeehae Park, Robert A. Pugh, Taekjip Ha, and Maria Spies

Shuo Wang, Manoj Munde, Siming Wang, W. David Wilson

Cytokine 51 (2010) Contents lists available at ScienceDirect. Cytokine. journal homepage:

Application Note. Kwasi Antwi, Amanda Ribar, Urban A. Kiernan, and Eric E. Niederkofler Thermo Fisher Scientific, Tempe, Arizona

Please note that in order to obtain useful results, the input values should be in the correct units (as indicated per input cell).

Biacore 8K. One solution for small molecule and biotherapeutic screening/characterization. GE Healthcare. Label-free interaction analysis

Tag-lite Tachykinin NK1 labeled Cells, ready-to-use (transformed & labeled), 200 tests* (Part# C1TT1NK1)

EPIGENTEK. EpiQuik Histone Demethylase LSD1 Activity/Inhibition Assay Kit. Base Catalog # P-3076 PLEASE READ THIS ENTIRE USER GUIDE BEFORE USE

Thermo Scientific Mass Spectrometric Immunoassay (MSIA) Pipette Tips. Next generation immunoaffinity. Robust quantitative platform

MSD Immuno-Dot-Blot Assays. A division of Meso Scale Diagnostics, LLC.

validation report for TaqMan Roundup Ready Quantification Kit

CHO Host Cell Proteins 3 rd Generation

RayBio Human bfgf ELISA Kit

Case Studies ZoBio

A2LA. R231 Specific Requirements: Threat Agent Testing Laboratory Accreditation Program. December 6, 2017

Biacore comparability tool for quantitating binding similarities in IgG Fcγ receptor analysis

Human Cytokine Assays: Tissue Culture Kit (96-well)

Performance of the Sievers 500 RL On-Line TOC Analyzer

PER.C6 cells Host Cell Proteins

Bio-Plex suspension array system

Converting your ELISA from horseradish peroxidase to alkaline phosphatase using NovaBright chemiluminescence detection reagents

Developing a natural partnership for rapid, sensitive identification of binding partners

Microarray Industry Products

Human Serum Albumin Assay

MSD GOLD Streptavidin and Avidin Plates

MagSi Beads. Magnetic Silica Beads for Life Science and Biotechnology study

Ligand Binding Assays: Summary and Consensus from the Bioanalytical Workshop (CC V)

BoTest A/E Botulinum Neurotoxin Detection Kit- Detailed Description

A handheld system for DNA test based on Lab on chip technologies. Marco Bianchessi

GSI Equine IL-10 ELISA Kit- Cell Lysate DataSheet

Fusion Analytical Method Validation

Universal Kinase Assay Kit (Fluorometric) For monitoring ADP formation, which is directly proportional to enzyme phosphotransferase activity

Protocol. NEXTERION Slide H. Protein application

Sodium Cyanoborohydride

Data Sheet. PD-1[Biotinylated]:PD-L2 Inhibitor Screening Assay Kit Catalog # Size: 96 reactions

Verification of Compendial Methods

Human IL10RB ELISA Pair Set ( CRFB4 )

Global Headquarters 86 Cummings Park Woburn, MA Tel:

MSD 96-Well MULTI-ARRAY and MULTI-SPOT Human Cytokine Assays: Base Kit

VALIDATION GUIDE FOR CHROMOGENIC ASSAY FOR ACTIZYME Anti-FIIa

Global Headquarters 86 Cummings Park Woburn, MA Tel:

Human Erythropoietin (EPO) kit

MSD 96-Well MULTI-ARRAY and MULTI-SPOT Mouse Cytokine Assays: Tissue Culture Kit

Human Interleukin 6 (IL6) Kit

Data Sheet. PD-1:PD-L1[Biotinylated] Inhibitor Screening Assay Kit Catalog # Size: 96 reactions

HOOK Sulfo-NHS-Biotin

Explore the future. Automotive Test Systems Process & Environmental Medical Semiconductor Scientific

Membrane Protein Arrays: Application for GPCR Screening

Human IgG Antigen ELISA Kit

Complementary use of Label-Free Real-Time Biosensors in Drug Discovery of Monoclonal Antibodies

Mouse ICAM-1 / CD54 ELISA Pair Set

doi: /s (03) J. Mol. Biol. (2003) 328,

User Manual. NGS Library qpcr Quantification Kit (Illumina compatible)

Highly Sensitive Surface Plasmon Resonance Sensor on Nanoscale Bioactive Surfaces for Specific Detection of Tri-Nitro Toluene

Application Note. Authors. Abstract

Fast and easy multiplex immunoassay development Cytokines as an example

Inline Conditioning system

protein interactions tech

Nanophotonics: principle and application. Khai Q. Le Lecture 11 Optical biosensors

Transcription:

Biacore Concentration Analysis Handbook

Biacore Concentration Analysis Handbook :IVWMSR%%(IGIQFIV

&MEGSVI 'SRGIRXVEXMSR%REP]WMW,ERHFSSO )HMXMSR(IGIQFIV:IVWMSR%% 'ST]VMKLX &MEGSVI%& %PPVMKLXWVIWIVZIH2STEVXWSJXLMWTYFPMGEXMSRQE]FIVITVSHYGIH [MXLSYX[VMXXIRTIVQMWWMSRJVSQ&MEGSVI%& &MEGSVI%&VIWIVZIWXLIVMKLXXSQEOIGLERKIWXSXLIHIWMKRERH GSRXIRXSJXLI'SRGIRXVEXMSR%REP]WMW,ERHFSSO[MXLSYXTVMSVRSXMGI &MEGSVIMWEVIKMWXIVIHXVEHIQEVOSJ&MEGSVI%& 7IRH]SYVGSQQIRXWF]IQEMPXSHIZIPSTFME$FMEGSVIGSQ &MEGSVI%& 6ETWKEXER 7)9TTWEPE7[IHIR 8IP *E\

Contents Contents 1. Introduction 1 4VMRGMTPIWSJ&MEGSVI &MEGSVIMRGSRGIRXVEXMSRQIEWYVIQIRX ;L]YWI&MEGSVI# %WWE]HIZIPSTQIRXSZIVZMI[ 2. Terminology 5 &MEGSVIXIVQMRSPSK] 4IVJSVQERGIGVMXIVME 7TIGMJMGMX]WIPIGXMZMX]ERHGVSWWVIEGXMZMX] %GGYVEG] 4VIGMWMSR 0MQMXSJHIXIGXMSR03( 0MQMXWSJUYERXMXEXMSR035 0MRIEVMX] 6ERKI 6SFYWXRIWW 7IRWMXMZMX] 3. Assay formats 15 (MVIGXFMRHMRKEWWE]W 7MRKPIWXITHMVIGXQIEWYVIQIRX 7ERH[MGLQIXLSHW -RHMVIGXEWWE]W -RLMFMXMSREWWE]W 7YVJEGIGSQTIXMXMSR &MRHMRKVEXIEWWE]W 'LSMGISJEWWE]XIGLRMUYI 'LSMGISJPMKERHERHSXLIVVIEKIRXW 4VEGXMGEPETTVSEGLIWXSVIEKIRXWIPIGXMSR (MVIGXFMRHMRKEWWE]W -RLMFMXMSREWWE]W 7YVJEGIGSQTIXMXMSREWWE]W 4. Surface preparation principles 27 7IRWSVWYVJEGITVSTIVXMIW 0MKERHMQQSFMPM^EXMSRQIXLSHW %QMRIGSYTPMRK 8LMSPGSYTPMRK M

Contents %PHIL]HIGSYTPMRK 7XVITXEZMHMRFMSXMRGETXYVI +IRIVEPGETXYVIQIXLSHW -QQSFMPM^MRKWQEPPQSPIGYPIW 'SRHMXMSRWJSVPMKERHMQQSFMPM^EXMSR &YJJIVGSRHMXMSRWERHTVIGSRGIRXVEXMSR 7XVEXIK]JSVWYVJEGITVITEVEXMSR %QSYRXSJMQQSFMPM^IHPMKERH 'LSMGISJMQQSFMPM^EXMSRQIXLSH 5. Surface preparation in practice 37 'SRHMXMSRWJSVMQQSFMPM^EXMSR -QQSFMPM^EXMSRTVSGIHYVI 4VITEVMRKWSPYXMSRW %QMRIGSYTPMRK 7YVJEGIXLMSPGSYTPMRK 0MKERHXLMSPGSYTPMRK %PHIL]HIGSYTPMRK 6IWYPXWSJMQQSFMPM^EXMSR 8IWXMRKXLIWYVJEGI 8VSYFPIWLSSXMRKWYVJEGITVITEVEXMSR 0S[MQQSFMPM^EXMSRPIZIPW 0S[EREP]XIVIWTSRWIW 6. Regeneration 49 6IKIRIVEXMSRWGSYXMRKWXVEXIK] 'LSMGISJVIKIRIVEXMSRWSPYXMSR 8IWXMRKVIKIRIVEXMSRGSRHMXMSRW -RXIVTVIXMRKVIKIRIVEXMSRWGSYXMRK 6ITSVXTSMRXTPEGMRK 8VIRHTPSXW 7. Developing and running concentration assays 55 %WWE]VIUYMVIQIRXWTIGMJMGEXMSR +IRIVEPTVEGXMGEPGSRWMHIVEXMSRW 4VITEVMRKWEQTPIW 6ITSVXTSMRXTPEGMRK %HNYWXMRKXLISTIVEXMRKVERKI (MVIGXFMRHMRKEWWE]W -RLMFMXMSREWWE]W 9R[ERXIHFMRHMRKSJEREP]XISVHIXIGXMRKQSPIGYPI XSXLIWIRWSVWYVJEGI 9R[ERXIHFMRHMRKMRHMVIGXFMRHMRKEWWE]W 9R[ERXIHFMRHMRKMRMRLMFMXMSRERHWYVJEGIGSQTIXMXMSR EWWE]W MM

Contents 8IWXMRKJSVYR[ERXIHFMRHMRK (IEPMRK[MXLYR[ERXIHFMRHMRK 7TIGMJMGMX]ERHGVSWWVIEGXMZMX] 1IEWYVMRKWTIGMJMGMX] 3TXMQM^MRKWTIGMJMGMX] 1EXVM\MRXIVJIVIRGI 2SRWTIGMJMGFMRHMRKXSXLIWIRWSVWYVJEGI 3XLIVQEXVM\MRXIVJIVIRGIIJJIGXW %WWE]WXEFMPMX] 8IWXMRKEWWE]WXEFMPX] (IEPMRK[MXLEWWE]WXEFMPMX]MWWYIW 6YRRMRKVSYXMRIEWWE]W 8. Measuring concentration in GxP environments 73 7IXXMRKYT+\4EWWE]W 7]WXIQTIVJSVQERGI %WWE]WIXXMRKW %WWE]TVSGIHYVIHSGYQIRXEXMSR (EXEWXSVEKI :EPMHEXMRK+\4EWWE]W 7TIGMJMGMX] %GGYVEG] 4VIGMWMSR 0MRIEVMX] 6ERKI 6SFYWXRIWW 6YRRMRK+\4EWWE]W (SGYQIRXXLIVYRWIXXMRKW (EXEWXSVEKI %YHMXXVEMPW A. The SPR detection principle 79 % 7YVJEGITPEWQSRVIWSRERGI % ;LEX746QIEWYVIW % &MEGSVIGSRJMKYVEXMSR B. Using binding rates to measure concentration 83 & *EGXSVWHIXIVQMRMRKFMRHMRKVEXIW & &MSGLIQMGEPMRXIVEGXMSRVEXIW & 1EWWXVERWTSVXTVSGIWWIW & ;LEXPMQMXWXLISFWIVZIHFMRHMRK# & %JJMRMX]MRHITIRHIRXEWWE]W & %HZERXEKIWSJEJJMRMX]MRHITIRHIRXEWWE]W & %JJMRMX]MRHITIRHIRXEWWE]WMRTVEGXMGI & 'EPMFVEXMSRMRHITIRHIRXEWWE]W MMM

Contents MZ

Introduction 1. Introduction 1.1 Principles of Biacore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iacore in concentration measurement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

Introduction 8LMWLERHFSSOTVSZMHIWKYMHIPMRIWJSVLS[XSHIZIPSTERHYWI GSRGIRXVEXMSREWWE]W[MXL&MEGSVIW]WXIQW8LIMRJSVQEXMSRMWKMZIREW JEVEWTSWWMFPIMRKIRIVEPXIVQW[MXLSYXHMVIGXVIJIVIRGIXSWTIGMJMG &MEGSVIW]WXIQW8LITVMRGMTPIWSJEWWE]HIZIPSTQIRXERH GSRGIRXVEXMSRHIXIVQMREXMSRGEREPWSFIETTPMIH[MXLETTVSTVMEXI EHNYWXQIRXWXSEWWE]WFEWIHSRSXLIVXIGLRSPSKMIW 1.3 Why use Biacore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

Introduction 1.4 Assay development overview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

Introduction

Terminology 2. Terminology 8LMWGLETXIVTVIWIRXWXLIXIVQMRSPSK]XLEXMWYWIHMRXLIGSRXI\XSJ GSRGIRXVEXMSRQIEWYVIQIRXW[MXL&MEGSVI8LIJMVWXWIGXMSRTVIWIRXW XIVQWWTIGMJMGXS&MEGSVIETTPMGEXMSRWERHXLIWIGSRHWIGXMSRHIJMRIW XLIXIVQWYWIHXSHIWGVMFIEWWE]TIVJSVQERGIMRXLIGSRXI\XSJ ZEPMHEXIHEREP]XMGEPTVSGIHYVIW 2.1 Biacore terminology &MEGSVIW]WXIQWQSRMXSVXLIMRXIVEGXMSRFIX[IIRX[SQSPIGYPIWSJ [LMGLSRIMWEXXEGLIHXSXLIWIRWSVWYVJEGIERHXLISXLIVMWJVIIMR WSPYXMSR8LIJSPPS[MRKXIVQWEVIYWIHMRXLIGSRXI\XSJGSRGIRXVEXMSR QIEWYVIQIRX[MXL&MEGSVI 8LITEVXRIVEXXEGLIHXSXLIWYVJEGIMWGEPPIHXLIPMKERH%XXEGLQIRX QE]FIGSZEPIRXSVXLVSYKLLMKLEJJMRMX]FMRHMRKXSERSXLIV QSPIGYPI[LMGLMWMRXYVRGSZEPIRXP]EXXEGLIHXSXLIWYVJEGIWII 'LETXIV-RXLIPEXXIVGEWIXLIQSPIGYPIEXXEGLIHXSXLIWYVJEGIMW VIJIVVIHXSEWXLIGETXYVMRKQSPIGYPI8LIXIVQlPMKERHzMW ETTPMIHLIVIMREREPSK][MXLXIVQMRSPSK]YWIHMREJJMRMX] GLVSQEXSKVETL]GSRXI\XWERHHSIWRSXMQTP]XLEXXLIWYVJEGI EXXEGLIHQSPIGYPIMWEPMKERHJSVEGIPPYPEVVIGITXSV 8LIEREP]XIMWXLIQSPIGYPIJSV[LMGLXLIGSRGIRXVEXMSRMWXSFI QIEWYVIH-RHMVIGXFMRHMRKEWWE]WXLIEREP]XIFMRHWHMVIGXP]XSXLI PMKERH-RMRLMFMXMSREWWE]WXLIGSRGIRXVEXMSRSJEREP]XIMW QIEWYVIHMRHMVIGXP]XLVSYKLFMRHMRKSJEREHHMXMSREPQSPIGYPI analyte analyte ligand ligand capturing molecule Figure 2-1. Ligand, analyte and capturing molecule in relation to the sensor surface. 8LIHIXIGXMRKQSPIGYPIMWXLIQSPIGYPIVIWTSRWMFPIJSVHIXIGXMRKXLI EREP]XI-RHMVIGXFMRHMRKEWWE]WXLIHIXIGXMRKQSPIGYPIMWXLIWEQI EWXLIPMKERH-RMRLMFMXMSREWWE]WXLIHIXIGXMRKQSPIGYPIMWXLI QSPIGYPIXLEXFMRHWXSXLIPMKERHERHKIRIVEXIWEVIWTSRWI[LMGLMW FPSGOIHF]XLITVIWIRGISJEREP]XI

Terminology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bsolute response (RU) Report points Relative response (RU) Buffer Sample Buffer Regeneration Buffer Time Figure 2-2. Schematic illustration of a sensorgram. The bars below the sensorgram curve indicate the solutions that pass over the sensor surface. 8LIWEQTPIQEXVM\MWXLIWSPYXMSRIRZMVSRQIRXMR[LMGLEREP]XIMW TVIWIRXMRWEQTPIW8LMWQE]FIEWMQTPI[IPPHIJMRIHWSPYXMSRWYGL EWEFYJJIVSVEGSQTPI\QM\XYVIWYGLEWEFSH]JPYMHGIPPI\XVEGX SVTVSHYGXJSVQYPEXMSR8LIXIVQQEXVM\MWEPWSYWIHXSVIJIVXS XLIGEVFS\]QIXL]PHI\XVERSRXLIWYVJEGISJXLIWIRWSVGLMTMR &MEGSVIEWHIWGVMFIHMR7IGXMSR8LMWYWEKIMWMRRS[E] GSRRIGXIHXSXLIXIVQWEQTPIQEXVM\

Terminology 2.2 Performance criteria,s[izivgsrgirxvexmsrmwqiewyvihxlivimwewixsjwxerhevhm^ih GVMXIVMEXLEXQIEWYVIXLITIVJSVQERGISJXLIEWWE][MXLMRERHFIX[IIR EWWE]SGGEWMSRW(SGYQIRXIHTIVJSVQERGIMWHIWMVEFPIMREPP GSRGIRXVEXMSRQIEWYVIQIRXWERHMWEVIUYMVIQIRXJSVZEPMHEXIHEWWE]W YWIHMRUYEPMX]GSRXVSPERHSXLIVGSRXI\XW8LIWXERHEVHTIVJSVQERGI GVMXIVMEHIJMRIHMRXLIJSPPS[MRKWIGXMSRWEVIFEWIHSRXLI-', VIGSQQIRHEXMSRW 'SRWMHIVEXMSRWSJLS[XSQIEWYVITIVJSVQERGI GVMXIVMEJSVEKMZIREWWE]EVIGSRWMHIVIHMR'LETXIV 2.2.1 Specificity, selectivity and cross-reactivity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

Terminology 100 Response/MW Compound A 50 Compound B 0 1 100 Concentration Figure 2-3. Cross-reactivity in a direct assay is determined from calibration curves of molecular weight-corrected response against concentration. In this illustration, compound B shows 1% cross-reactivity with compound A. 2.2.2 Accuracy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recision 8LITVIGMWMSRSJEREWWE]HIWGVMFIWXLIEKVIIQIRXHIKVIISJWGEXXIV FIX[IIRVIWYPXSFXEMRIHJVSQQYPXMTPIQIEWYVIQIRXWSRXLIWEQI LSQSKIRISYWWEQTPI4VIGMWMSRQE]FIHIXIVQMRIHEXXLVIIPIZIPW 6ITIEXEFMPMX]MWXLITVIGMWMSRSJXLIEWWE]YRHIVXLIWEQISTIVEXMRK GSRHMXMSRW[MXLXLIWEQIWEQTPISZIVEWLSVXTIVMSHSJXMQI

Terminology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

Terminology Response CV response CV dose Concentration Figure 2-4. CV response is an indication of the variability in the response for a given analyte concentration. CV dose is an indication of the variability in calculated concentration derived from a given set of measurements. %GGYVEG]ERHTVIGMWMSREVIJVIUYIRXP]GSRJYWIHMRGSQQSRTEVPERGI EPXLSYKLXLI]EVIGPIEVP]HMWXMRKYMWLIHMRXLIMVJSVQEPHIJMRMXMSRW%R EWWE]XLEXMWTVIGMWIFYXRSXEGGYVEXI[MPPEP[E]WKMZIXLIWEQI [VSRKERW[IV[LMPISRIXLEXMWEGGYVEXIFYXRSXTVIGMWI[MPPKMZIER ETTVS\MQEXIFYXGSVVIGXERW[IV 2.2.4 Limit of detection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imits of quantitation (LOQ) (IXIVQMREXMSRSJXLI035SJEREWWE]VIUYMVIWXLEXXLITVIGMWMSRERH EGGYVEG]SJXLIEWWE]EVIQIEWYVIHSZIVEVERKISJEREP]XI GSRGIRXVEXMSRWMRSVHIVXSHIXIVQMRIXLIGSRGIRXVEXMSRWEFSZIERH FIPS[[LMGLXLITIVJSVQERGIMWEGGITXEFPI8LIWIGSRGIRXVEXMSRWEVI

Terminology XLIRXLI035WHMJJIVIRXZEPYIWQE]FIETTPMGEFPIEGGSVHMRKXS [LIXLIVTVIGMWMSRMWHIXIVQMRIHEWMRXIVQIHMEXITVIGMWMSRSV VITVSHYGMFMPMX]8LI035WLSYPHRSXFIFEWIHSRVITIEXEFMPMX]SV MRXVEEWWE]TVIGMWMSRWMRGIXLIZEPYILEWPMXXPIQIERMRKMRVIJIVIRGIXS EWMRKPIEWWE]SGGEWMSR 8LIPS[IVPMQMXSJUYERXMXEXMSR0035MWXLIPS[IWXEREP]XI GSRGIRXVEXMSRXLEXGERFIQIEWYVIH[MXLWYMXEFPITVIGMWMSRERH EGGYVEG]8LIPIZIPGSVVIWTSRHMRKXSlWYMXEFPIz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esponse 3xSD acceptable precision and accuracy Limit of detection Limits of quantitation Concentration Figure 2-5. Limits of detection and quantitation.

Terminology 2.2.6 Linearity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ange 8LIVERKISJEREWWE]MWXLIMRXIVZEPFIX[IIRERHMRGPYHMRKXLIYTTIV ERHPS[IVPMQMXWSJUYERXMXEXMSRMIXLIVERKI[MXLMR[LMGLXLI TVIGMWMSREGGYVEG]ERHPMRIEVMX]EVIEGGITXEFPI %TEVEQIXIVSJXIRUYSXIHMRVIPEXMSRXSXLIVERKIMWXLIEREP]XI GSRGIRXVEXMSRXLEXKMZIWSJXLIQE\MQYQVIWTSRWI& JSVE HMVIGXFMRHMRKEWWE]-' JSVERMRLMFMXMSREWWE]2SXIXLEXXLMWMWRSX RIGIWWEVMP]XLIQMHTSMRXSJXLIGSRGIRXVEXMSRVERKI Response/MW 100% Response 100% 50% 50% 0 B 50 Concentration 0 IC 50 Concentration Figure 2-6. B 50 (direct assays, left panel) and IC 50 (inhibition assays, right panel) are the analyte concentration that gives 50% of the maximum response.

Terminology 2.2.8 Robustness 8LIVSFYWXRIWWSJEREWWE]MWEQIEWYVISJMXWGETEGMX]XSVIQEMR YREJJIGXIHF]ZEVMEXMSRWMRQIXLSHTEVEQIXIVW6SFYWXRIWWMWVIPEXIH XSMRXIVQIHMEXITVIGMWMSRSVVYKKIHRIWW;LMPIMRXIVQIHMEXITVIGMWMSR VIJIVWXSXLIIJJIGXSJYRMRXIRXMSREPZEVMEXMSRWFIX[IIREWWE]SGGEWMSRW STIVEXSVIXGWII7IGXMSRVSFYWXRIWWMWHIXIVQMRIHF]QIERWSJ HIPMFIVEXIZEVMEXMSRWMRGLSWIREWWE]TEVEQIXIVW%REWWE]XLEXMW VSFYWX[MXLVIWTIGXXSEPPIWWIRXMEPTEVEQIXIVW[MPPEPWSLEZIELMKL PIZIPSJMRXIVQIHMEXITVIGMWMSR 2.2.9 Sensitivity 8LIWIRWMXMZMX]SJEREWWE]MWRSXMRGPYHIHEQSRKXLIVIGSQQIRHIH TIVJSVQERGIGVMXIVMEJSVZEPMHEXMSRFYXMW[SVXL]SJEHIJMRMXMSRLIVI FIGEYWIXLIXIVQMWSJXIRYWIHMRWIZIVEPHMJJIVIRXERHXSWSQII\XIRX GSRJPMGXMRKWIRWIW*SVQEPP]WIRWMXMZMX]MWHIJMRIHEWXLIEWWE]VIWTSRWI TIVYRMXEREP]XIGSRGIRXVEXMSRIK69TIV KQPSV69 18LMWMW XLIWPSTISJXLIWXERHEVHGYVZIJSVXLIEWWE]*SVEWWE]W[LIVIXLI WXERHEVHGYVZIMWRSXPMRIEVXLIWIRWMXMZMX]ZEVMIW[MXLXLIEREP]XI GSRGIRXVEXMSR8LIXIVQlWIRWMXMZMX]zMWLS[IZIVWSQIXMQIWYWIHEWE W]RSR]QJSV03(SV035XLIPS[IWXGSRGIRXVEXMSRXLEXGERFI HIXIGXIHSVQIEWYVIHSVVIWSPYXMSRXLIWQEPPIWXHMJJIVIRGIMR GSRGIRXVEXMSRXLEXGERFIHIXIVQMRIH[MXLGSRJMHIRGI&MEGSVI VIGSQQIRHWYWEKISJXLIXIVQMRXLIJMVWXWIRWIEWWE]VIWTSRWITIV YRMXEREP]XIGSRGIRXVEXMSR Response Sensitivity = slope Concentration Figure 2-7. Sensitivity is the response per unit analyte concentration, which is the slope of the calibration curve. The sensitivity varies over the range of the assay if the calibration curve is not linear.

Terminology

Assay formats 3. Assay formats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

Assay formats analyte analyte enhancement molecule ligand ligand Direct binding assay 1 2 Direct binding assay with enhancement detecting molecule competing analyte analyte analyte ligand ligand Inhibition assay (solution competition) Surface competition assay Figure 3-1. Schematic illustration of four different approaches to concentration measurement with Biacore. 3.1 Direct binding assays &MRHMRKPIZIPEWWE]WVITVIWIRXXLIQSWXHMVIGXETTVSEGLXSQIEWYVMRK GSRGIRXVEXMSR[MXL&MEGSVI8LIHIXIGXMRKQSPIGYPIMWEXXEGLIHXSXLI WIRWSVGLMTWYVJEGIWEQTPIMWMRNIGXIHERHXLIVIWTSRWISFXEMRIHEJXIV EJM\IHGSRXEGXXMQIMWQIEWYVIH8LIVIWTSRWIMWVIPEXIHXSEREP]XI GSRGIRXVEXMSR[MXLXLILIPTSJEWXERHEVHGYVZITVITEVIHF]EREP]^MRK ORS[RGSRGIRXVEXMSRWSJEREP]XIYRHIVXLIWEQIGSRHMXMSRW 3.1.1 Single step direct measurement (MVIGXQIEWYVIQIRXMWWYMXEFPIJSVQEGVSQSPIGYPEVEREP]XIW QSPIGYPEV[IMKLX"HEPXSRW[LMGLKMZIERIEWMP]QIEWYVIH VIWTSRWIIZIREXPS[QSPEVGSRGIRXVEXMSRW (YVMRKMRNIGXMSRSJWEQTPIXLIVIWTSRWIMRGVIEWIWEWEJYRGXMSRSJ XMQIEWEREP]XIFMRHWXSXLIWYVJEGIVIEGLMRKEWXIEH]WXEXIZEPYIMJXLI GSRXEGXXMQIMWWYJJMGMIRXP]PSRK(ITIRHMRKSRXLIXMQIEX[LMGLXLI

Assay formats VIWTSRWIMWQIEWYVIHXLIWIRWMXMZMX]ERHSTIVEXMRKVERKISJXLIEWWE] [MPPFIHMJJIVIRX*MKYVI Response 2 1 Response 1 2 Time Concentration Figure 3-2. A single step direct assay gives an increasing response with increasing concentration. The range and sensitivity are determined in part by the time at which the response is measured: an interaction that is allowed to approach equilibrium will give a higher sensitivity at low analyte concentrations. The inset shows the sensorgrams from which the calibration curves are derived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andwich methods 7ERH[MGLQIXLSHWEVIERI\XIRWMSRSJXLIWMRKPIWXITHMVIGXETTVSEGL EJXIVEREP]XILEWFSYRHXSXLIWYVJEGIEXXEGLIHPMKERHEWIGSRHEV] MRXIVEGXERXXLIIRLERGIQIRXQSPIGYPIMWMRNIGXIHXSFMRHXSXLI EREP]XIERHIRLERGIXLIEREP]XIVIWTSRWI-JXLIWIGSRHEV]EREP]XIMWE

Assay formats PEVKIVQSPIGYPIXLERXLIEREP]XIXLIWIGSRHEV]VIWTSRWI[MPPFI TVSTSVXMSREPP]LMKLIVXLERXLITVMQEV]VIWTSRWISFXEMRIHJVSQXLI EREP]XIMXWIPJTVSZMHMRKEREQTPMJMGEXMSRSJXLIWMKREP*MKYVI Response 2 1 Response 1 2 Time Concentration Figure 3-3. Sensorgrams (inset) and calibration curves for a direct binding assay with enhancement. : primary response (analyte), : secondary response (enhancement reagent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

Assay formats 3.2 Indirect assays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nhibition assays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esponse Response Concentration log[concentration] Figure 3-4. Inhibition and surface competition assays give a calibration curve where the response is inversely related to the analyte concentration. Calibration curves are often shown on a log[concentration] scale (right panel) to expand the low concentration region. 'PIEVP]MXMWIWWIRXMEPXLEXHIXIGXMRKQSPIGYPIWGEVV]MRKFSYRHEREP]XI MRWSPYXMSRWLSYPHRSXFIEFPIXSFMRHXSXLIWYVJEGIEXXEGLIHPMKERH -HIEPP]XLI,1;HIXIGXMRKQSPIGYPIWLSYPHFIQSRSZEPIRXJSVXLMW

Assay formats VIEWSR,S[IZIVQSRSGPSREPERXMFSHMIWEVIGSQQSRP]YWIHEW HIXIGXMRKQSPIGYPIWMRWTMXISJXLIMVFMZEPIRXFMRHMRKTVSTIVXMIW)ZIR XLSYKLFSXLERXMKIRFMRHMRKWMXIWQYWXFISGGYTMIHXSIJJIGXMZIP] MRLMFMXXLIFMRHMRKSJERXMFSH]XSXLIWYVJEGIXLIMRLMFMXMSREWWE] TVMRGMTPIWXMPP[SVOWVIPMEFP]ERHERXMFSHMIWEVISJXIRXLIQSWXVIEHMP] EZEMPEFPIWSYVGISJHIXIGXMRKQSPIGYPIW 8LIEJJMRMX]SJXLIHIXIGXMRKQSPIGYPIJSVXLIEREP]XIMRWSPYXMSR XSKIXLIV[MXLXLIGSRGIRXVEXMSRSJHIXIGXMRKQSPIGYPIHIXIVQMRIWXLI YWIJYPVERKISJERMRLMFMXMSREWWE],MKLIVEJJMRMXMIWEPPS[ QIEWYVIQIRXEXPS[IVEREP]XIGSRGIRXVEXMSRWFYXEPWSVIWYPXMRE REVVS[IVSTIVEXMRKVERKI*MKYVI-RJSVQEPXIVQWXLI-' SJER MRLMFMXMSREWWE]MWKMZIRF] -' = /( + ' [LIVI/ ( MWXLIIUYMPMFVMYQHMWWSGMEXMSRGSRWXERXJSVXLIMRXIVEGXMSR [MXLEREP]XIERH'MWXLIXSXEPGSRGIRXVEXMSRSJHIXIGXMRKQSPIGYPI-J XLIGSRGIRXVEXMSRMWQYGLWQEPPIVXLERXLIHMWWSGMEXMSRGSRWXERXXLI VERKI[MPPFIHIXIVQMRIHTVMQEVMP]F]XLIEJJMRMX]GSRZIVWIP]MJXLI GSRGIRXVEXMSRMWQYGLLMKLIVXLERXLIHMWWSGMEXMSRGSRWXERXXLIVERKI [MPPFIHIXIVQMRIHTVMQEVMP]F]XLIGSRGIRXVEXMSR Response Increasing affinity Increasing concentration of detecting molecule log[concentration] Figure 3-5. Increasing the affinity of the detecting molecule moves the operating range to lower analyte concentration and also narrows the range. -RLMFMXMSREWWE]WEVIQSWXGSQQSRP]YWIHJSV01;EREP]XIW8LI] QE]LS[IZIVEPWSFIYWIHEWEREPXIVREXMZIXSHMVIGXFMRHMRKPIZIP EWWE]WJSVQEGVSQSPIGYPEVEREP]XIWMRWMXYEXMSRW[LIVI MQQSFMPM^EXMSRSVVIKIRIVEXMSRSJXLIHIXIGXMRKQSPIGYPISRXLIWIRWSV WYVJEGIMWRSXWEXMWJEGXSV]

Assay formats 3.2.2 Surface competition -RXLIWYVJEGIGSQTIXMXMSRETTVSEGLEFMRHMRKTEVXRIVXSXLIEREP]XI MWYWIHEWPMKERHERHELMKLQSPIGYPEV[IMKLXEREPSKYIXSXLIEREP]XI X]TMGEPP]EREP]XIGSRNYKEXIHXSEGEVVMIVTVSXIMRMWEHHIHMRGSRWXERX EQSYRXXSXLIWEQTPIWXSFIQIEWYVIH8LIFEWMWSJXLIEWWE]MW GSQTIXMXMSRFIX[IIREREP]XIERHXLI,1;EREPSKYIJSVFMRHMRKXS XLIPMKERH*MKYVI8LIQIEWYVIHVIWTSRWIMWXLIWYQSJXLI GSRXVMFYXMSRWJVSQEREP]XIERH,1;QSPIGYPIEW[MXLXLIWSPYXMSR GSQTIXMXMSRETTVSEGLXLIVIWTSRWIMWMRZIVWIP]VIPEXIHXSXLIEQSYRX SJEREP]XIMRXLIWEQTPIWII*MKYVI -R&MEGSVIGSRXI\XWWYVJEGIGSQTIXMXMSREWWE]WKIRIVEPP]VIP]SR QIEWYVIQIRXSJXLIVEXISJFMRHMRKXSXLIWYVJEGI-RXLIWEQI[E]EW JSVHMVIGXFMRHMRKEWWE]WMXMWRSXRIGIWWEV]JSVXLIMRXIVEGXMSRSJ EREP]XISVEREPSKYI[MXLXLIWYVJEGIXSVIEGLEWXIEH]WXEXI8LMW GSRXVEWXW[MXLMRLMFMXMSREWWE]W[LIVIXLIMRXIVEGXMSRSJEREP]XI[MXL XLIHIXIGXMRKQSPIGYPIMRWSPYXMSRWLSYPHVIEGLIUYMPMFVMYQFIJSVIXLI WEQTPIMWMRNIGXIHSZIVXLIWYVJEGI 8LIWYVJEGIGSQTIXMXMSRETTVSEGLGERLEZIEHZERXEKIWSZIVXLIQSVI GSQQSRMRLMFMXMSREWWE]JSVQEXMRWMXYEXMSRW[LIVIMQQSFMPM^EXMSRSJ XLIEREP]XISRXLIWIRWSVGLMTWYVJEGITVIWIRXWTVSFPIQW01; EREP]XIWXLEXEVIX]TMGEPP]EHHVIWWIH[MXLGSQTIXMXMSREWWE]WEVIRSX EP[E]WEQIREFPIXSXLIGLIQMWXV]HIZIPSTIHJSVEXXEGLMRK QEGVSQSPIGYPEVPMKERHWXSXLIWYVJEGIERHHIZIPSTQIRXSJEWYMXEFPI MQQSFMPM^EXMSRQIXLSHJSVEREP]XI[LMGLTVIWIVZIWXLIEFMPMX]XSFMRH HIXIGXMRKQSPIGYPIGERFIEXMQIGSRWYQMRKTVSGIWW-XGERMRQER] GEWIWFIWMQTPIVXSHIZIPSTEQIXLSHJSVGSRNYKEXMRKXLIEREP]XI QSPIGYPIXSEGEVVMIVTVSXIMR8LITVSTIVXMIWSJXLIGEVVMIVTVSXIMREVI RSXMQTSVXERXTVSZMHIHXLEXEMXMWPEVKIIRSYKLXSKMZIEVIWTSRWI GPIEVP]HMWXMRKYMWLEFPIJVSQXLEXKMZIRF]EREP]XIEPSRIFMXHSIWRSX FMRHSRMXWS[RXSXLIWIRWSVGLMTWYVJEGI[MXLEXXEGLIHPMKERHERHG XLIGSRNYKEXIHEREP]XIQSPIGYPIWEVIWXMPPEZEMPEFPIJSVFMRHMRKXSXLI PMKERH8LIPIZIPSJGSRNYKEXMSRWLSYPHFIOITXPS[EREZIVEKISJSRI SVPIWWEREP]XIQSPIGYPIWTIVGEVVMIVTVSXIMRXSEZSMHEZMHMX]IJJIGXW XLEXEVMWIJVSQQYPXMTPIPMKERHFMRHMRKWMXIW8LMWKMZIWGSRWMHIVEFPI JVIIHSQMRXLIGLSMGISJGEVVMIVQSPIGYPIJVIUYIRXP]EGLIETERH VIEHMP]EZEMPEFPITVSXIMRPMOIXVERWJIVVMRSVLETXSKPSFYPMR MWJYPP] EHIUYEXIJSVXLITYVTSWI%ZSMHYWMRKWIVYQEPFYQMRJSVXLMWTYVTSWI WMRGIMXFMRHWXSQER]WQEPPQSPIGYPIW

Assay formats 3.3 Binding rate assays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esponse Initial binding rate Binding level Figure 3-6. Binding rate and binding level measurements. Time &MRHMRKVEXIQIEWYVIQIRXWERHXLIGSRHMXMSRWVIUYMVIHJSVXLIMVYWI EVIGSRWMHIVIHMR%TTIRHM\&

Assay formats 3.4 Choice of assay technique %WHMWGYWWIHEFSZI&MEGSVIW]WXIQWSJJIVERYQFIVSJHMJJIVIRX ETTVSEGLIWXSQIEWYVMRKGSRGIRXVEXMSR8LIGLSMGISJETTVSEGLMW HMGXEXIHPEVKIP]F]XLIGLEVEGXIVMWXMGWSJXLIEREP]XIFIMRKEWWE]IHERH XSWSQII\XIRXF]XLITYVTSWISJXLIEWWE]ERHXLIX]TISJWEQTPI QEXVM\XLEX[MPPFIYWIH8LIXEFPIFIPS[TVSZMHIWWSQIKIRIVEP KYMHIPMRIW 1EGVSQSPIGYPIW X]TMGEPP]1; "HEPXSRW (MVIGXEWWE][MXLXLIHIXIGXMRKQSPIGYPI EXXEGLIHXSXLIWIRWSVWYVJEGI 7ERH[MGLEWWE]GERLIPTXS reqtpmj]xliviwtsrwijsvqspigypiwexxli PS[IRHSJXLIWM^IVERKI rgsrjmvqxlimhirxmx]sjxlierep]ximr GSQTPI\QM\XYVIW rgsrjmvqxlimrxikvmx]sjqypxmjyrgxmsrep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

Assay formats 3.5 Choice of ligand and other reagents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ractical approaches to reagent selection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irect binding assays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

Assay formats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nhibition assays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

Assay formats 3.5.4 Surface competition assays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

Sensor Chip CM5 Certified Grade Surface preparation principles 4. Surface preparation principles 1IEWYVIQIRXW[MXL&MEGSVIEVIFEWIHSRMRXIVEGXMSRSJEREP]XIMR WSPYXMSR[MXLPMKERHEXXEGLIHXSXLIWIRWSVGLMT1SPIGYPIWGERFI EXXEGLIHXSXLIGLMTWYVJEGIIMXLIVGSZEPIRXP]YWMRKEZEVMIX]SJ GLIQMGEPQIXLSHWSVXLVSYKLLMKLEJJMRMX]GETXYVIXSEWTIGMJMG GETXYVMRKQSPIGYPI[LMGLMWMRXYVREXXEGLIHGLIQMGEPP]XSXLI WYVJEGI 8LMWGLETXIVKMZIWERSZIVZMI[SJXLIQIXLSHWEZEMPEFPIJSVEXXEGLMRK XLIPMKERHXSXLIWIRWSVGLMTWYVJEGI4VEGXMGEPTVSGIHYVIWEVI HIWGVMFIHMRXLIRI\XGLETXIV %VERKISJWIRWSVGLMTWMWEZEMPEFPIJSVYWIMR&MEGSVIW]WXIQW8LI QSWXZIVWEXMPIMW7IRWSV'LMT'1EKIRIVEPTYVTSWIGLMT[MXLELMKL WYVJEGIGETEGMX]XLEXWYTTSVXWE[MHIVERKISJPMKERHMQQSFMPM^EXMSR GLIQMWXVMIW-RJSVQEXMSRMRXLMWGLETXIVVIPEXIWXS7IRWSV'LMT'1 YRPIWWSXLIV[MWIWXEXIH(IXEMPWSJSXLIVWYVJEGIWQE]FISFXEMRIH JVSQ&MEGSVI 4.1 Sensor surface properties 8LIWIRWSVGLMTMWEKPEWWWPMHIGSEXIH[MXLEXLMRPE]IVSJKSPHXS [LMGLEQEXVM\SJGEVFS\]QIXL]PEXIHHI\XVERMWGSZEPIRXP]EXXEGLIH *MKYVI8LIKSPHMWVIUYMVIHJSVKIRIVEXMSRSJXLI746VIWTSRWI %TTIRHM\%0MKERHWGERFIEXXEGLIHXSXLIHI\XVERQEXVM\YWMRKE ZEVMIX]SJGLIQMGEPQIXLSHW Dextran matrix Gold layer Glass Figure 4-1. Schematic illustration of the structure of the sensor chip surface.

Surface preparation principles 8LIKSPHPE]IVERHHI\XVERQEXVM\SRXLIWIRWSVWYVJEGIEVIWXEFPI YRHIVE[MHIVERKISJGSRHMXMSRWMRGPYHMRKI\XVIQIWSJT,ERH QSHIVEXIGSRGIRXVEXMSRWSJQER]SVKERMGWSPZIRXW3RGIXLIPMKERH LEWFIIRMQQSFMPM^IHXLIWXEFMPMX]SJXLIWIRWSVWYVJEGIMWHIXIVQMRIH TVMQEVMP]F]XLIWXEFMPMX]SJXLIEXXEGLIHPMKERH 4.2 Ligand immobilization methods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mine coupling %QMRIGSYTPMRKGLIQMWXV]MWXLIQSWX[MHIP]ETTPMGEFPIETTVSEGLJSV EXXEGLMRKFMSQSPIGYPIWGSZEPIRXP]XSXLIWIRWSVWYVJEGI;MXLXLMW QIXLSHXLIHI\XVERQEXVM\SRXLIWIRWSVGLMTWYVJEGIMWJMVWXEGXMZEXIH [MXLEQM\XYVISJIXL]PHMQIXL]PEQMRSTVST]PGEVFSHMMQMHI )('ERH2L]HVS\]WYGGMRMQMHI2,7XSKMZIVIEGXMZIWYGGMRMQMHI IWXIVW0MKERHMWXLIRTEWWIHSZIVXLIWYVJEGIERHXLIIWXIVWVIEGX WTSRXERISYWP][MXLYRGLEVKIHEQMRSKVSYTWSVSXLIVRYGPISTLMPMG KVSYTWXSPMROXLIPMKERHGSZEPIRXP]XSXLIHI\XVERWII*MKYVI

Surface preparation principles Figure 4-2. Amine coupling of ligands to the sensor surface. 1SWXTVSXIMRWGSRXEMRWIZIVEPEQMRIKVSYTWWSXLEXIJJMGMIRX EXXEGLQIRXGERFIEGLMIZIH[MXLSYXWIVMSYWP]EJJIGXMRKXLIFMSPSKMGEP EGXMZMX]SJXLIPMKERH-RWSQIMRWXERGIWLS[IZIVEQMRIGSYTPMRKQE] MRZSPZIKVSYTWEXSVRIEVXLIEGXMZIWMXISVFMRHMRKWMXISJXLIPMKERH [MXLXLIVIWYPXXLEXEXXEGLQIRXMWEGGSQTERMIHF]PSWWSJEGXMZMX]-R WYGLGEWIWXLIPMKERHGERFIEXXEGLIHYWMRKEPXIVREXMZIGSYTPMRK GLIQMWXV]SVEGETXYVMRKETTVSEGL 4.2.2 Thiol coupling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l Figure 4-3. PDEA Thiol coupling reagent, 2-(2-pyridinyldithio)ethaneamine hydrochloride.

Surface preparation principles /LJDQGWKLRO 6XUIDFHWKLRO Figure 4-4. Ligand thiol and surface thiol coupling of ligands to the sensor surface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ldehyde coupling 0MKERHWGSRXEMRMRKEPHIL]HIKVSYTWIMXLIVREXMZISVMRXVSHYGIHF] S\MHEXMSRSJGMWHMSPWGERFIMQQSFMPM^IHEJXIVEGXMZEXMRKXLIWYVJEGI [MXLL]HVE^MRISVGEVFSL]HVE^MHI8LIGLIQMWXV]SJEPHIL]HIGSYTPMRK MWWYQQEVM^IHMR*MKYVI Figure 4-5. Aldehyde coupling of ligands to the sensor surface.

Surface preparation principles %PHIL]HIGSYTPMRKTVSZMHIWEREPXIVREXMZIETTVSEGLJSVMQQSFMPM^MRK KP]GSTVSXIMRWERHSXLIVKP]GSGSRNYKEXIW8LIQIXLSHMWTEVXMGYPEVP] WYMXEFPIJSVPMKERHWGSRXEMRMRKWMEPMGEGMHWMRGIXLIWIVIWMHYIWEVIZIV] IEWMP]S\MHM^IHXSEPHIL]HIW 4.2.4 Streptavidin-biotin capture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eneral capture methods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

Surface preparation principles 8LIFEWMGVIUYMVIQIRXJSVWYGGIWWJYPGETXYVMRKMWEVSFYWXLMKLEJJMRMX] MRXIVEGXMSRFIX[IIRXLIGETXYVMRKQSPIGYPIERHXLIPMKERH 1SRSGPSREPERXMFSHMIWEVIJVIUYIRXP]YWIHEWGETXYVMRKEKIRXW)ZIRMJ XLIEJJMRMX]MWLMKLXLIVI[MPPSJXIRFIEGIVXEMREQSYRXSJHMWWSGMEXMSR SJXLIPMKERHJVSQXLIWYVJEGIHYVMRKXLIGSYVWISJEREREP]WMW7MRGI PMKERHMWVIJVIWLIHJSVIEGLG]GPIXLMWGERKIRIVEPP]FIMKRSVIHMR GSRGIRXVEXMSREWWE]W 8LIGETXYVMRKQSPIGYPIMWEXXEGLIHXSXLIWYVJEGIYWMRKSRISJXLI GSZEPIRXGLIQMGEPETTVSEGLIWHIWGVMFIHMRXLITVIZMSYWWIGXMSRW 4.2.6 Immobilizing small molecules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